Pro-Larva – the new medical grade anti-viral mask

Pro-Larva – the new medical grade anti-viral mask

Proven to kill up to 99.9% of coronaviruses for over 7 hours*


Provides a physical barrier for users against ingress of pathogens, microorganisms, body fluids, and particles.


Pro-Larva is a brand developed to commercialise its proprietary nanoparticle technology within antiviral purposes, focusing specifically on the Pro-Larva mask. The mask was designed by Nottingham Trent University scientist and nanotechnology expert, Dr Gareth Cave, and Pharm2Farm’s scientists. It was developed and tested following a UK Government Innovate UK grant, as part of UK Research and Innovation’s response to COVID-19.

The mask has European approval (CE marked), and its proprietary α-virion™ layer has been certified to ISO 18184 standards. The product is manufactured under sterile conditions.


*Within 5 minutes of contact, clinically proven by Virology Research Services Ltd, independent UK virology centre

Send a Message

An email will be sent to the owner